Yasunaga K, Kokawa T, Fujitake H, Nomura S, Kageyama T, Ohyabu H, Tatsumi N, Im T, Park K, Kawagoe H
1st Department of Internal Medicine, Kansai Medical University.
Rinsho Ketsueki. 1991 Sep;32(9):938-44.
High-dose intravenous immunoglobulin (IVIG) for idiopathic thrombocytopenic purpura (ITP) produces a dramatic and substantial increase in platelet count, but the increased count tends to return rapidly to its pretreatment level. We studied the effects of immunosuppressive treatment aimed at the maintenance of platelet counts following the IVIG administration in ITP. Thirty-five patients with ITP were treated with IVIG, and then thirty-two of them with an immunosuppressant (azathioprine) and a glucocorticoid (prednisolone). After IVIG, the platelet count increased significantly. With immunosuppressive therapy after IVIG, most patients had a tendency to maintain the counts. In particular, this maintaining effect was remarkable in those patients who had been responsive to the standard prednisolone therapy while non-responders to the prior prednisolone failed to maintain the counts. When prednisolone was given after IVIG, the effect of maintaining platelet counts was dose-dependent. The treatment with azathioprine and prednisolone after IVIG appears to be effective in maintenance of platelet counts.
大剂量静脉注射免疫球蛋白(IVIG)治疗特发性血小板减少性紫癜(ITP)可使血小板计数显著大幅增加,但增加的计数往往会迅速恢复到治疗前水平。我们研究了免疫抑制治疗对ITP患者静脉注射免疫球蛋白后维持血小板计数的效果。35例ITP患者接受了静脉注射免疫球蛋白治疗,其中32例随后接受了免疫抑制剂(硫唑嘌呤)和糖皮质激素(泼尼松龙)治疗。静脉注射免疫球蛋白后,血小板计数显著增加。静脉注射免疫球蛋白后进行免疫抑制治疗,大多数患者倾向于维持计数。特别是,这种维持作用在那些对标准泼尼松龙治疗有反应而对先前泼尼松龙无反应的患者中尤为显著。当在静脉注射免疫球蛋白后给予泼尼松龙时,维持血小板计数的效果呈剂量依赖性。静脉注射免疫球蛋白后用硫唑嘌呤和泼尼松龙治疗似乎对维持血小板计数有效。